The protein levels of FASN were also elevated in the patients with steatosis and further elevated in the patients with NASH-fibrosis, whereas protein levels of both DNMT3A and SHP were not significantly changed in these patients compared to normal subjects (Fig. 9b). The gene discussed is DNMT3A; the disease is metabolic dysfunction-associated steatohepatitis.